MRK logo Merck & Co. +
Merck & Co.
+
Revenue breakdown by Products & Services
Revenue breakdown by Geography

Merck & Co.'s Revenue by Region

In fiscal year 2025, Merck & Co.'s revenue by geographical region are as follows:

  • Asia Pacific: $2.98 B
  • CHINA: $1.94 B
  • EMEA: $14.58 B
  • International: $2.88 B
  • JAPAN: $2.71 B
  • Latin America: $3.41 B
  • UNITED STATES: $36.51 B

Learn more about Merck & Co.’s Revenue by Products

Check out competitors to Merck & Co. in a side-by-side comparison.

Explore additional financial metrics for Merck & Co..

Continue reading...

The above chart shows Merck & Co.'s revenue percentage share by geographical region.

In fiscal year 2023, Merck & Co.'s revenue by region is as follows:

  • Animal Health segment generated $5.63 B in revenue, representing 9.36% of its total revenue.
  • Other Segments generated $907.00 M in revenue, representing 1.51% of its total revenue.
  • Pharmaceutical segment generated $53.58 B in revenue, representing 89.13% of its total revenue.

The biggest region for Merck & Co. is the Pharmaceutical segment, which represents 89.13% of its total revenue.
The smallest region for Merck & Co. is the Other Segments, which represents 1.51% of its total revenue.

The above chart shows Merck & Co.'s revenue percentage share by geographical region.

In fiscal year 2024, Merck & Co.'s revenue by region is as follows:

  • Asia Pacific generated $3.06 B in revenue, representing 4.77% of its total revenue.
  • CHINA generated $5.49 B in revenue, representing 8.56% of its total revenue.
  • EMEA generated $14.04 B in revenue, representing 21.88% of its total revenue.
  • International generated $2.56 B in revenue, representing 3.99% of its total revenue.
  • JAPAN generated $3.28 B in revenue, representing 5.11% of its total revenue.
  • Latin America generated $3.46 B in revenue, representing 5.39% of its total revenue.
  • UNITED STATES generated $32.28 B in revenue, representing 50.3% of its total revenue.

The biggest region for Merck & Co. is the UNITED STATES, which represents 50.3% of its total revenue.
The smallest region for Merck & Co. is the International, which represents 3.99% of its total revenue.

The above chart shows Merck & Co.'s revenue percentage share by geographical region.

In fiscal year 2025, Merck & Co.'s revenue by region is as follows:

  • Asia Pacific generated $2.98 B in revenue, representing 4.59% of its total revenue.
  • CHINA generated $1.94 B in revenue, representing 2.98% of its total revenue.
  • EMEA generated $14.58 B in revenue, representing 22.43% of its total revenue.
  • International generated $2.88 B in revenue, representing 4.43% of its total revenue.
  • JAPAN generated $2.71 B in revenue, representing 4.17% of its total revenue.
  • Latin America generated $3.41 B in revenue, representing 5.25% of its total revenue.
  • UNITED STATES generated $36.51 B in revenue, representing 56.16% of its total revenue.

The biggest region for Merck & Co. is the UNITED STATES, which represents 56.16% of its total revenue.
The smallest region for Merck & Co. is the CHINA, which represents 2.98% of its total revenue.
Continue reading...

Summary Table

Geography (Percent Share) 2023 2024 2025
Animal Health segment 9.36% 0% 0%
Asia Pacific 0% 4.77% 4.59%
CHINA 0% 8.56% 2.98%
EMEA 0% 21.88% 22.43%
International 0% 3.99% 4.43%
JAPAN 0% 5.11% 4.17%
Latin America 0% 5.39% 5.25%
Other Segments 1.51% 0% 0%
Pharmaceutical segment 89.13% 0% 0%
UNITED STATES 0% 50.3% 56.16%
Total Revenue 100% 100% 100%

The above chart shows the revenue trend of different segments of Merck & Co..

In fiscal year 2025, the UNITED STATES generated the most revenue ($36.51 B), and the CHINA generated the least revenue ($1.94 B).

The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.

  • Asia Pacific revenue decreased -2.45% ($75.00 M) from $3.06 B (in 2024) to $2.98 B (in 2025).
  • CHINA revenue decreased -64.71% ($3.56 B) from $5.49 B (in 2024) to $1.94 B (in 2025).
  • EMEA revenue increased 3.84% ($539.00 M) from $14.04 B (in 2024) to $14.58 B (in 2025).
  • International revenue increased 12.47% ($319.00 M) from $2.56 B (in 2024) to $2.88 B (in 2025).
  • JAPAN revenue decreased -17.35% ($569.00 M) from $3.28 B (in 2024) to $2.71 B (in 2025).
  • Latin America revenue decreased -1.42% ($49.00 M) from $3.46 B (in 2024) to $3.41 B (in 2025).
  • UNITED STATES revenue increased 13.11% ($4.23 B) from $32.28 B (in 2024) to $36.51 B (in 2025).
    • Continue reading...

    Summary Table

    Region 2023
    Value Change
    		2024
    Value Change
    		2025
    Value Change
    Animal Health segment $5.63 B - - - - -
    Asia Pacific - - $3.06 B - $2.98 B
    2.45%
    CHINA - - $5.49 B - $1.94 B
    64.71%
    EMEA - - $14.04 B - $14.58 B
    3.84%
    International - - $2.56 B - $2.88 B
    12.47%
    JAPAN - - $3.28 B - $2.71 B
    17.35%
    Latin America - - $3.46 B - $3.41 B
    1.42%
    Other Segments $907.00 M - - - - -
    Pharmaceutical segment $53.58 B - - - - -
    UNITED STATES - - $32.28 B - $36.51 B
    13.11%
    Total Revenue $60.12 B - $64.17 B
    6.74%
    		$65.01 B
    1.31%

    Frequently Asked Questions

    What was Merck & Co.'s largest region last year?

    In fiscal year 2025, UNITED STATES revenue reached $36.51 Billion, representing 56.16% of Merck & Co.'s total revenue and making it the largest region for the company.

    Which region experienced the highest growth for Merck & Co. last year?

    The UNITED STATES is Merck & Co.'s highest growth region, with a revenue growth of +13.11% in 2025 compared to 2024.

    Related company

    Revenue Ranking

    Revenue Ranking

    Related

    Submit feedback to Bullfincher